Stocktoria
InspireMD, Inc. NSPR
InspireMD, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.0M | $7.0M | $6.2M | $5.2M | $4.5M | $2.5M | $3.7M | $3.6M | $2.8M | $1.9M |
| Gross profit | $2.6M | $1.5M | $1.8M | $1.1M | $754,000 | $83,000 | $756,000 | $995,000 | $585,000 | $102,000 |
| R&D expense | $15.0M | $13.6M | $8.0M | $7.8M | $5.2M | $2.2M | $3.0M | $1.5M | $1.3M | $1.3M |
| Operating income | -$49.6M | -$33.5M | -$21.1M | -$18.7M | -$14.7M | -$10.4M | -$9.8M | -$7.6M | -$8.2M | -$7.6M |
| Interest expense | — | — | — | — | — | — | — | — | $119,000 | $721,000 |
| Income tax | $63,000 | $59,000 | $65,000 | $28,000 | $45,000 | $4,000 | $24,000 | — | $27,000 | $1,000 |
| Net income | -$48.8M | -$32.0M | -$19.9M | -$18.5M | -$14.9M | -$10.5M | -$10.0M | -$7.2M | -$8.4M | -$8.5M |
| EPS (diluted) | $-0.76 | $-0.76 | $-0.82 | $-0.78 | — | — | — | — | — | — |
| Operating cash flow | -$35.1M | -$21.9M | -$16.4M | -$15.5M | -$13.2M | -$9.1M | -$9.8M | -$7.6M | -$8.1M | -$7.5M |
| Free cash flow | -$36.8M | -$23.3M | -$16.8M | -$16.0M | -$13.6M | -$9.2M | -$10.1M | -$7.7M | -$8.4M | -$7.5M |
| Cash & equivalents | $8.9M | $18.9M | $9.6M | $4.6M | $12.0M | $12.6M | $5.5M | $9.4M | $3.7M | $7.5M |
| Inventory | $3.4M | $2.6M | $2.1M | $1.6M | $1.1M | $1.4M | $1.2M | $1.1M | $533,000 | $500,000 |
| Total assets | $69.4M | $46.8M | $47.6M | $24.7M | $39.7M | $17.8M | $9.9M | $12.3M | $6.1M | $9.4M |
| Total liabilities | $14.2M | $10.7M | $8.1M | $7.3M | $6.2M | $5.6M | $4.5M | $3.5M | $3.1M | $5.4M |
| Shareholders' equity | $55.2M | $36.1M | $39.5M | $17.4M | $33.5M | $12.2M | $5.4M | $8.8M | $2.7M | $4.0M |
Growth · year-over-year · Revenue CAGR 18.9%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +28.1% | +13.0% | +20.0% | +15.0% | +80.9% | -33.2% | +3.3% | +30.4% | +45.8% | -18.0% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.